Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ibn Albeetar Trading is a leading Iraqi healthcare distribution and marketing company headquartered in Baghdad. Established in 1994, the company serves as a critical strategic partner for multinational pharmaceutical and medical device manufacturers seeking to enter or expand within the Iraqi market. Their comprehensive service suite includes regulatory registration, specialized cold-chain logistics, and commercialization strategies for both the public and private sectors. Ibn Albeetar represents global industry leaders such as Sanofi, AstraZeneca, and GSK, ensuring the availability of essential medicines across the country. The company plays a pivotal role in the Iraqi healthcare infrastructure by bridging the gap between international innovation and local patient needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ibn Albeetar Trading.